INSULIN DEGLUDEC/LIRAGLUTIDE (combination product) (Xultophy®)

Clinical Indication

Diabetes

Comments

For those who have not had the training.

Date of classification

September 2015

Yellow

Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.